AdaptHealth/$AHCO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AdaptHealth
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Ticker
$AHCO
Sector
Primary listing
Employees
10,500
Headquarters
Website
AdaptHealth Metrics
BasicAdvanced
$1.2B
16.65
$0.54
1.59
-
Price and volume
Market cap
$1.2B
Beta
1.59
52-week high
$11.63
52-week low
$7.11
Average daily volume
855K
Financial strength
Current ratio
1.058
Quick ratio
0.743
Long term debt to equity
118.587
Total debt to equity
122.332
Interest coverage (TTM)
2.24%
Profitability
EBITDA (TTM)
650.048
Gross margin (TTM)
22.68%
Net profit margin (TTM)
2.49%
Operating margin (TTM)
8.09%
Effective tax rate (TTM)
42.97%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
3.88%
Return on equity (TTM)
5.51%
Valuation
Price to earnings (TTM)
16.651
Price to revenue (TTM)
0.372
Price to book
0.74
Price to tangible book (TTM)
-1.03
Price to free cash flow (TTM)
5.213
Free cash flow yield (TTM)
19.18%
Free cash flow per share (TTM)
1.717
Growth
Revenue change (TTM)
-0.61%
Earnings per share change (TTM)
-110.19%
3-year revenue growth (CAGR)
5.00%
3-year earnings per share growth (CAGR)
-13.29%
What the Analysts think about AdaptHealth
Analyst ratings (Buy, Hold, Sell) for AdaptHealth stock.
Bulls say / Bears say
AdaptHealth delivered a full‐year 2024 net income of $90.4 million compared to a $678.9 million loss in 2023, while adjusted EBITDA grew 2.7% to $688.7 million and free cash flow increased to $235.8 million, reflecting a strong financial turnaround (AdaptHealth).
In Q4 2024, the company beat expectations with adjusted EPS of $0.34 versus $0.28 consensus and revenue of $856.6 million topping estimates of $829.2 million, demonstrating effective execution in a challenging environment (Investing.com).
In Q1 2025, cash flow from operations rose to $95.5 million from $49.0 million a year earlier and free cash flow nearly breakeven at −$0.1 million versus −$38.9 million, underscoring significant improvement in working capital and liquidity management (AdaptHealth).
In Q1 2025, AdaptHealth’s net revenue fell 1.8% year-over-year to $777.9 million and adjusted EBITDA declined 19.3% to $127.9 million, highlighting operational headwinds early in the year (AdaptHealth).
During Q2 2025, net income dropped to $14.7 million from $19.4 million a year earlier and adjusted EBITDA contracted 5.9% to $155.5 million, underscoring ongoing margin pressure in core segments (AdaptHealth).
The company’s fiscal 2025 guidance for net revenue of $3.22 billion–$3.36 billion implies organic growth of −1% to +3%, signaling only modest top-line expansion amidst a competitive home medical equipment market (AdaptHealth).
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.
AdaptHealth Financial Performance
Revenues and expenses
AdaptHealth Earnings Performance
Company profitability
AdaptHealth News
AllArticlesVideos
Halper Sadeh LLC Encourages AdaptHealth Corp. Shareholders to Contact the Firm to Discuss Their Rights
Business Wire4 days ago
AdaptHealth Corp. Announces Third Quarter 2025 Earnings Release Date and Conference Call
Business Wire3 weeks ago
AdaptHealth Corp. to Participate in Upcoming Investor Conference
Business Wire1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AdaptHealth stock?
AdaptHealth (AHCO) has a market cap of $1.2B as of October 31, 2025.
What is the P/E ratio for AdaptHealth stock?
The price to earnings (P/E) ratio for AdaptHealth (AHCO) stock is 16.65 as of October 31, 2025.
Does AdaptHealth stock pay dividends?
No, AdaptHealth (AHCO) stock does not pay dividends to its shareholders as of October 31, 2025.
When is the next AdaptHealth dividend payment date?
AdaptHealth (AHCO) stock does not pay dividends to its shareholders.
What is the beta indicator for AdaptHealth?
AdaptHealth (AHCO) has a beta rating of 1.59. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.